Check-Cap Ltd.
MBAI
Check-Cap Ltd. is a clinical-stage medical diagnostics company focused on capsule-based colorectal cancer screening. The company develops C-Scan, an ingestible imaging capsule system designed to detect precancerous polyps and other abnormalities in the colon using a preparation-free, non-invasive approach. Its technology is intended to support earlier identification of colorectal disease while offering a more patient-friendly alternative to traditional screening methods. Check-Cap Ltd. operates in the health technology and medical devices space, serving the growing demand for accessible diagnostic tools in preventive care. The company is based in Isfiya, Israel, and its current business centers on advancing screening solutions for clinical use and broader adoption in colorectal health management.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
$4M
▲ +116.5% YoY
Op. Margin
–
ROIC
-104.47%
▼ -41.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$46K
▲ +99.4% YoY
Op. Cash Flow (TTM)
-$46K
▲ +99.4% YoY
Net Debt
-$203K
Net Cash Position
Cash & Equiv.
$219K
Continue Research
Peers
Software - Infrastructure · Pick stocks to compare with MBAI
Check-Cap (MBAI) in three numbers
Questions about Check-Cap
Is Check-Cap (MBAI) overvalued?
Check-Cap trades at 3.65 times earnings. Intrinsiqq's fair value calculator has no opening value for MBAI, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.
Is Check-Cap a high-quality business?
Check-Cap scores 20 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 5 checks computed from company filings. Its best check is net debt at -$203000, and its weakest is return on capital at -104.5%. The Quality tab shows every check against its target.
Does Check-Cap (MBAI) pay a dividend?
No. Check-Cap (MBAI) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: company filings. Price: last close 6 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing MBAI
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.